UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported): February 18, 2014
MEDICAN ENTERPRISES, INC.
(Exact name of registrant as specified in charter)
Nevada
(State or other jurisdiction of incorporation)
|
000-53408
|
87-0474017
|
|
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
|
5955 Edmond Street, Suite 102
Las Vegas, NV 89118
|
||
|
(Address of Principal Executive Offices)
|
||
|
(702) 826-3365
|
||
|
(Registrant’s Telephone Number, Including Area Code)
|
||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:
|
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
o
|
Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b))
|
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 5.02 Appointment of Certain Officers.
The Board of Directors of Medican Enterprises, Inc. (“Medican”) appointed of Wayne Hansen as Chief Financial Officer of Medican. Mr. Hansen, 71, has an extensive history of corporate financial management. He is President of Caulfield Capital Management Inc. and was formerly a Managing Partner of Asia Liaison and Practice Partner at BDO Dunwoody. Mr. Hansen’s appointment is effective immediately.
SIGNATURES
In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
Medican Enterprises, Inc.
|
|||
|
February 18, 2014
|
By:
|
/s/Kenneth Williams
|
|
|
Kenneth Williams
|
|||
|
Chief Executive Officer and Director
|
|||